According to gene dysregulation analysis, the regulatory intensity of RUNX3→GPR15 is decreased from normal to cancer (Figure 2A), which suggests that RUNX3 at least partly contributes to the high expression of GPR15 in normal. This evidence concerns the gene GPR15 and cancer.